Yellow Sky Biology Group

Yellow Sky Biology Group appears to be a very small, early-stage private biotechnology company referenced publicly in connection with psychedelic and hybrid fungi/plant biology work. The company is not well documented in mainstream corporate, financing, or clinical-development sources, and the limited public evidence suggests it was mentioned as an affiliated company of a Blue Sun Mycology Group founder rather than as a broadly operating standalone drug developer. Based on the available information, Yellow Sky Biology Group was associated with plans for a joint venture called Scarlet Begonias Biotech focused on plant-fungi hybrids. No validated evidence was found of clinical programs, marketed products, regulatory filings, substantial partnerships, or public-market activity. Because the public footprint is extremely limited, many company attributes remain unverified.